Rashtriya Newsflash

Lipodystrophy Clinical Trial Emerging Lipodystrophy therapeutic approaches include leptin receptor agonists, apolipoprotein C-III inhibitors, angiopoietin-like protein 3 (ANGPTL3) antagonists, and gene-based therapies. Lipodystrophy companies such as Regeneron Pharmaceuticals and other

Hypertriglyceridemia Pipeline Key Hypertriglyceridemia companies such as NorthSea Therapeutics, Arrowhead Pharmaceuticals, and Ionis Pharmaceuticals are leveraging advanced technologies such as RNA interference and antisense platforms to develop highly targeted therapies.

Von Willebrand’s Disease Clinical Trial Key Von Willebrand’s Disease Companies include Star Therapeutics, Hemab, Vega Therapeutics, and others The Von Willebrand’s Disease (VWD) therapeutic landscape is entering a phase of

DelveInsight’s “Breast Cancer Pipeline Insight 2026” report provides comprehensive insights about 250+ Breast Cancer companies and 300+ pipeline drugs in the Breast Cancer pipeline landscape. It covers the Breast Cancer